Price $4.28 |
Market Cap
146M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.25
|
P/S
1.68
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-18.4K
|
FCF
-0.5
|
|
Op. Margin
-25.80%
|
Net Margin
-25.60%
|
ROE
-29.80%
|
ROI
-13.50%
|
|
ROA
-23.70%
|
EPS Growth
-
|
Current Ratio
4.1
|
Debt/Equity
0.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Celexus Inc (CXUS) | $1.35 | - | - | 5.2M | Strong Buy |
| Cocrystal Pharma Inc (COCP) | $2.20 | - | - | 74.4M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.10 | - | - | 87.4M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.27 | - | - | 10.6M | Strong Buy |
| Dynatronics Corporation (DYNT) | $1.34 | - | - | 12.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
